Bayesian Capital Management’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,050
Closed -$21.8K 992
2023
Q3
$21.8K Buy
+1,050
New +$31.9K ﹤0.01% 652

Other funds holding RMTI

Bayesian Capital Management's RMTI Position: Q4 2023 in Review

Bayesian Capital Management sold out of Rockwell Medical (RMTI) in Q4 2023, closing a stake of 1,050 shares — an estimated $21.8K sold.

Bayesian Capital Management first reported a position in RMTI in Q3 2023 and held it in 1 quarter. The position peaked at $21.8K in Q3 2023. 34 funds tracked by Wall St. Rank hold RMTI as of Q4 2023.

  • Bayesian Capital Management reported no remaining Rockwell Medical position as of Q4 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 1,050 Rockwell Medical shares in Q4 2023, an estimated $21.8K.
  • Bayesian Capital Management first reported a position in Rockwell Medical in Q3 2023 and held it in 1 quarter.
  • Bayesian Capital Management's Rockwell Medical position peaked at $21.8K in Q3 2023.
  • 34 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2023.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.